Terms: = Head and neck cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Treatment
179 results:
1. Nomogram for predicting electrocoagulation syndrome after endoscopic submucosal dissection of esophageal tumors.
Liao F; Shen Z; Rong J; Zhu Z; Pan X; Wang C; Long S; Zhou X; Li G; Zhu Y; Chen Y; Shu X
Surg Endosc; 2024 Apr; 38(4):1877-1883. PubMed ID: 38307960
[TBL] [Abstract] [Full Text] [Related]
2. Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.
Hosonuma M; Hirasawa Y; Kuramasu A; Murayama M; Narikawa Y; Toyoda H; Baba Y; Isobe J; Funayama E; Tajima K; Shida M; Hamada K; Tsurui T; Ariizumi H; Ishiguro T; Suzuki R; Ohkuma R; Kubota Y; Horiike A; Sambe T; Tsuji M; Wada S; Kiuchi Y; Kobayashi S; Tsunoda T; Yoshimura K
Cancer Sci; 2024 Mar; 115(3):752-762. PubMed ID: 38254257
[TBL] [Abstract] [Full Text] [Related]
3. Comparing pyrotinib with trastuzumab and pertuzumab with trastuzumab for HER2-positive metastatic breast cancer: a retrospective, multicenter analysis.
You S; Xie Y; Sang D; Luo T; Yuan P; Xu F; Wang B
Front Endocrinol (Lausanne); 2023; 14():1325540. PubMed ID: 38149099
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic role of pathologic status other than complete response after neoadjuvant therapy followed by surgery in esophageal squamous cell carcinoma.
Park SY; Lee J; Oh D; Sun JM; Yun J; Jeon YJ; Cho JH; Choi YS; Zo JI; Shim YM; Kim HK
Esophagus; 2024 Jan; 21(1):51-57. PubMed ID: 38082188
[TBL] [Abstract] [Full Text] [Related]
5. A systematic review and meta-analysis of prognostic indicators in patients with head and neck malignancy treated with immune checkpoint inhibitors.
Kang D; Liu S; Yuan X; Liu S; Zhang Z; He Z; Yin X; Mao H
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18215-18240. PubMed ID: 38078963
[TBL] [Abstract] [Full Text] [Related]
6. Construction and validation of a risk-scoring model to predict lymph node metastasis in T1b-T2 esophageal cancer.
Lin JP; Chen XF; Chen WJ; Wang PY; He H; Zhuang FN; Zhou H; Chen YJ; Wei WW; Liu SY; Wang F
Surg Endosc; 2024 Feb; 38(2):640-647. PubMed ID: 38012439
[TBL] [Abstract] [Full Text] [Related]
7. Tryptophan metabolism regulates inflammatory macrophage polarization as a predictive factor for breast cancer immunotherapy.
Xue L; Wang C; Qian Y; Zhu W; Liu L; Yang X; Zhang S; Luo D
Int Immunopharmacol; 2023 Dec; 125(Pt B):111196. PubMed ID: 37972471
[TBL] [Abstract] [Full Text] [Related]
8. Incidence, severity, and temporal development of oral complications in pediatric allogeneic hematopoietic stem cell transplant patients - a multicenter study.
Agholme MB; Dahllöf G; Törlén JK; Majorana A; Brennan MT; von Bültzingslöwen I; Tan PL; Hu S; Sim YF; Hong C
Support Care Cancer; 2023 Nov; 31(12):702. PubMed ID: 37971651
[TBL] [Abstract] [Full Text] [Related]
9. A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
Ho AL; Foster NR; Deraje Vasudeva S; Katabi N; Antonescu CR; Frenette GP; Pfister DG; Erlichman C; Schwartz GK
Cancer; 2024 Mar; 130(5):702-712. PubMed ID: 37947157
[TBL] [Abstract] [Full Text] [Related]
10. Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.
Janjigian YY; Kawazoe A; Bai Y; Xu J; Lonardi S; Metges JP; Yanez P; Wyrwicz LS; Shen L; Ostapenko Y; Bilici M; Chung HC; Shitara K; Qin SK; Van Cutsem E; Tabernero J; Li K; Shih CS; Bhagia P; Rha SY;
Lancet; 2023 Dec; 402(10418):2197-2208. PubMed ID: 37871604
[TBL] [Abstract] [Full Text] [Related]
11. Quality Performance Indicators for the Surgical Management of Oesophageal cancer: A Systematic Literature Review.
Kulasegaran S; Wang Y; Woodhouse B; MacCormick A; Srinivasa S; Koea J
World J Surg; 2023 Dec; 47(12):3262-3269. PubMed ID: 37865917
[TBL] [Abstract] [Full Text] [Related]
12. Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
Honma Y; Ikeda M; Hijioka S; Matsumoto S; Ito T; Aoki T; Furuse J
Invest New Drugs; 2023 Dec; 41(6):777-786. PubMed ID: 37856005
[TBL] [Abstract] [Full Text] [Related]
13. Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
Baba T; Kusumoto M; Kato T; Kurihara Y; Sasaki S; Oikado K; Saito Y; Endo M; Fujiwara Y; Kenmotsu H; Sata M; Takano T; Kato K; Hirata K; Katagiri T; Saito H; Kuwano K
Int J Clin Oncol; 2023 Dec; 28(12):1585-1596. PubMed ID: 37787866
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of progression-free survival as a surrogate endpoint for overall survival in locally advanced or metastatic differentiated thyroid cancer: a systematic review.
Yang S; Zhan J; Xu X
Endocrine; 2023 Dec; 82(3):491-497. PubMed ID: 37702900
[TBL] [Abstract] [Full Text] [Related]
15. Identification of Proteomic Biomarkers in Proliferative Verrucous Leukoplakia through Liquid Chromatography With Tandem Mass Spectrometry.
Arroyo E; Pérez Sayáns M; Bravo SB; de Oliveira Barbeiro C; Paravani Palaçon M; Chamorro Petronacci CM; García Vence M; Chantada Vázquez MDP; Blanco Carrión A; Suárez Peñaranda JM; García García A; Gándara Vila P; Días Almeida J; Veríssimo da Costa GC; Sousa Nogueira FC; Medeiros Evaristo JA; de Abreu Pereira D; Rintala M; Salo T; Rautava J; Padín Iruegas E; Oliveira Alves MG; Morandin Ferrisse T; Albergoni da Silveira H; Esquiche León J; Vilela Silva E; Flores IL; Bufalino A
Lab Invest; 2023 Oct; 103(10):100222. PubMed ID: 37507024
[TBL] [Abstract] [Full Text] [Related]
16. Long non-coding RNA LINC00958 and microRNA miR-627-5p provide candidate diagnostic biomarker and participate tumor progression in laryngeal squamous cell carcinoma: a retrospective study.
Zhang C; Ma R
J Physiol Pharmacol; 2023 Apr; 74(2):. PubMed ID: 37453096
[TBL] [Abstract] [Full Text] [Related]
17. Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity cancer.
Dayan GS; Bahig H; Johnson-Obaseki S; Eskander A; Hong X; Chandarana S; de Almeida JR; Nichols AC; Hier M; Belzile M; Gaudet M; Dort J; Matthews TW; Hart R; Goldstein DP; Yao CMKL; Hosni A; MacNeil D; Fowler J; Higgins K; Khalil C; Khoury M; Mlynarek AM; Morand G; Sultanem K; Maniakas A; Ayad T; Christopoulos A
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):961-969. PubMed ID: 37422839
[TBL] [Abstract] [Full Text] [Related]
18. Radiomics for therapy-specific head and neck squamous cell carcinoma survival prognostication (part I).
Bernatz S; Böth I; Ackermann J; Burck I; Mahmoudi S; Lenga L; Martin SS; Scholtz JE; Koch V; Grünewald LD; Koch I; Stöver T; Wild PJ; Winkelmann R; Vogl TJ; Dos Santos DP
BMC Med Imaging; 2023 Jun; 23(1):71. PubMed ID: 37268876
[TBL] [Abstract] [Full Text] [Related]
19. KRAS mutations upregulate Runx1 to promote occurrence of head and neck squamous cell carcinoma.
Deng M; Guo J; Ling Z; Zhang C; He L; Fan Z; Cheng B; Xia J
Mol Carcinog; 2023 Sep; 62(9):1284-1294. PubMed ID: 37222390
[TBL] [Abstract] [Full Text] [Related]
20. Benchmarking the Radiation Oncology Alternative Payment Model: Changes in Medicare Reimbursement for 16 Common Radiation Therapy treatment Courses.
Hogan JS; Karraker P; Fischer-Valuck BW; Vapiwala N; Mehta MP; Perez CA; Baumann JC; Bradley JD; Baumann BC
Pract Radiat Oncol; 2023; 13(5):e389-e394. PubMed ID: 37172757
[TBL] [Abstract] [Full Text] [Related]
[Next]
